ALB and cancer: This strategy was demonstrated by the site‐selective conjugation of NHC*−Au−Cl to albumin and the antibody trastuzumab with the aim of enhancing stability and blood circulation half‐time as well as biodistribution to cancer tissues of the gold‐based anticancer drug.